Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

Ancaman blokir Wikipedia: Tanda kuatnya hasrat negara mengontrol narasi publik

shutterstock(Pixinoo/Shutterstock)● Ancaman blokir Wikipedia menandai obsesi negara memperluas kontrol atas infrastruktur pengetahuan publik.● Regulasi menjadi instrumen yang memaksa platf...

Bukan cuma ikan sapu-sapu, ada banyak spesies invasif di perairan kita termasuk ikan nila

● Spesies invasif seperti ikan sapu-sapu, red devil, ikan cere, dan nila merupakan ancaman serius bagi ikan-ikan lokal.● Penyebaran spesies invansif terjadi akibat aktivitas manusia (perda...

Toleransi di ruang digital: Bagaimana tayangan Youtube ‘Login’ menggeser metode dakwah konvensional

● Media sosial mengubah ekspresi toleransi yang kaku, elitis, dan ‘top-down’ menjadi lebih cair dan egaliter.● Program seperti ‘Login’ membumikan isu agama yang ber...